FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 80 filers reported holding FORTRESS BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $139,000 | -51.7% | 102,400 | -11.2% | 0.00% | -33.3% |
| Q4 2021 | $288,000 | -27.1% | 115,297 | -6.1% | 0.00% | -25.0% |
| Q3 2021 | $395,000 | -13.8% | 122,798 | -4.2% | 0.00% | 0.0% |
| Q2 2021 | $458,000 | -23.4% | 128,177 | -24.4% | 0.00% | -33.3% |
| Q1 2021 | $598,000 | +19.8% | 169,526 | +7.6% | 0.01% | 0.0% |
| Q4 2020 | $499,000 | – | 157,570 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |